Blood test may cut unnecessary hospital stays for pre-eclampsia

NCT ID NCT05228002

Completed Diagnosis Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at whether a blood test measuring the sFlt-1/PlGF ratio can help doctors decide if women with suspected pre-eclampsia need to be hospitalized. Pre-eclampsia is a serious pregnancy condition that can harm both mother and baby, but diagnosing it is tricky. The study involved 43 pregnant women and compared standard care to using the blood test results to guide decisions. The goal was to see if the test could reduce hospital stays without missing complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sFlt-1/PlGF ratio blood test
What this could lead to: If successful, this could lead to a simple blood test that helps doctors decide which women with suspected pre-eclampsia need hospital care, reducing unnecessary hospitalizations.
What could go wrong: This is a small, completed study with only 43 participants, so results may not apply broadly. The test is not yet standard practice, and more research is needed to confirm its benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRE-ECLAMPSIA

Contacts and locations

Locations

Nice University Hospital

Nice, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.